— Know what they know.
Not Investment Advice

IRLA Earnings

IRulya Therapeutics Inc.
1W: -7.2% 1M: +10.3% 3M: +45.4% YTD: +966.0% 1Y: +1717.0% 3Y: +3133.6% 5Y: -43.9%
$32.48
+1.09 (+3.49%)
After Hours: $32.50 (+0.02, +0.08%)
Weekly Expected Move ±19.9%
$21 $27 $34 $41 $48
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 56 · $31.9M mcap · 981269 float · 6.54% daily turnover · Short 52% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Next Earnings 2026-11-11
EPS Estimate
$-1.45
Range: $-1.56 - $-1.34

Estimate vs Actual

Earnings Surprise History

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-14 quarter 2028-03-30 $— $-2.45 ▼ 2.45 $— $—
2026-10-14 annual 2029-12-31 $— $-4.71 ▼ 4.71 $— $—
2026-10-14 annual 2028-12-31 $— $-4.72 ▼ 4.72 $— $—
2026-10-14 annual 2027-12-31 $— $-4.57 ▼ 4.57 $— $—
2026-10-14 annual 2026-12-31 $— $-9.20 ▼ 9.20 $— $—
2026-10-14 annual 2025-12-31 $— $-218.84 ▼ 218.84 $— $—
2026-10-14 quarter 2028-12-30 $— $-2.73 ▼ 2.74 $— $—
2026-10-14 quarter 2028-09-30 $— $-2.64 ▼ 2.64 $— $—
2026-10-14 annual 2030-12-31 $— $-5.32 ▼ 5.32 $— $—
2026-10-14 quarter 2028-06-30 $— $-2.54 ▼ 2.54 $— $—
2026-10-14 quarter 2027-12-30 $— $-1.32 ▼ 1.32 $— $—
2026-10-14 quarter 2027-09-30 $— $-1.30 ▼ 1.30 $— $—
2026-10-14 quarter 2027-06-30 $— $-1.23 ▼ 1.23 $— $—
2026-10-14 quarter 2027-03-30 $— $-1.23 ▼ 1.23 $— $—
2026-10-14 quarter 2026-12-30 $— $-1.45 ▼ 1.45 $— $—
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms